An Australia-wide diabetes pilot led by the University of Sydney is seeking primary care providers to share their views.
The type 1 diabetes national screening pilot, a research study that aims to find out if and how screening for type 1 diabetes should be offered to children in Australia, rolled out across the country in 2022-23.
Over 1,000 children were screened by a free, simple, finger prick dried bloodspot test to detect type 1 diabetes autoantibodies.
Health professionals play a pivotal role in shaping the potential implementation of a nationwide screening program, and primary care providers – regardless of their involvement in the pilot – are invited to share their views and experiences about screening in a short online survey.
The valuable feedback will inform if and how type 1 diabetes screening should be offered as a national screening program to Australian children in the future.
The survey (which can be accessed here), is expected to take 5 to 10 minutes.
A $25 Prezzee e-gift card is offered upon completion, and submissions close Friday, 31 May 2024.
If you have questions, contact the pilot research team at info@kidsdiabetesscreen.com.au or phone 1800 505 909 (Mon-Fri, 9am-4pm). You can also visit our website here.
The Type 1 Diabetes National Screening Pilot is led by the University of Sydney, with collaborating universities and hospitals around Australia. It is funded by JDRF, a research foundation for type 1 diabetes. This study has been approved by the Sydney Children’s Hospitals Network Human Research Ethics Committee (Approval Number: 2022/ETH00537).
Disclaimer: This article was provided by The University of Sydney. While every effort has been made to ensure the information is accurate, North Western Melbourne Primary Health Network does not warrant or represent the accuracy, currency and completeness of any information or material included within.
